Who invested in Rubius Therapeutics?
Rubius Therapeutics's investors include Flagship Pioneering.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$300Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by FinSMEsSEC filing: $101M sold, first sale Feb 2018
From the SEC filings it signed: 4 on the team.
On the board, as filediCatherine B. SohnDavid Straight EpsteinFrancis B. CussMichael S. RosenblattNoubar B. AfeyanRobert S. LangerRoger S. Pomerantz
Rubius Therapeutics's investors include Flagship Pioneering.
Rubius Therapeutics has raised $300M across 2 rounds since 2018.
Rubius Therapeutics's most recent round was an Undisclosed round of $200M in Mar 2021.
Its most recent round, $200M in Mar 2021, is also its largest on record.
Rubius Therapeutics's first round on record, in Mar 2021, was backed by Flagship Pioneering.
Rubius Therapeutics's latest named round is an Undisclosed round, in Mar 2021.
Rubius Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.